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METHODOLOGY
Multi-year optimization of malaria 
intervention: a mathematical model
Harry J. Dudley1, Abhishek Goenka2, Cesar J. Orellana2 and Susan E. Martonosi2*
Abstract 
Background: Malaria is a mosquito-borne, lethal disease that a ects millions and kills hundreds of thousands of 
people each year, mostly children. There is an increasing need for models of malaria control. In this paper, a model 
is developed for allocating malaria interventions across geographic regions and time, subject to budget constraints, 
with the aim of minimizing the number of person-days of malaria infection.
Methods: The model considers a range of several conditions: climatic characteristics, treatment e cacy, distribution 
costs, and treatment coverage. An expanded susceptible-infected-recovered compartment model for the disease 
dynamics is coupled with an integer linear programming model for selecting the disease interventions. The model 
produces an intervention plan for all regions, identifying which combination of interventions, with which level of 
coverage, to use in each region and year in a 5-year planning horizon.
Results: Simulations using the model yield high-level, qualitative insights on optimal intervention policies: The opti-
mal intervention policy is di erent when considering a 5-year time horizon than when considering only a single year, 
due to the e ects that interventions have on the disease transmission dynamics. The vaccine intervention is rarely 
selected, except if its assumed cost is signi cantly lower than that predicted in the literature. Increasing the available 
budget causes the number of person-days of malaria infection to decrease linearly up to a point, after which the 
bene t of increased budget starts to taper. The optimal policy is highly dependent on assumptions about mosquito 
density, selecting di erent interventions for wet climates with high density than for dry climates with low density, and 
the interventions are found to be less e ective at controlling malaria in the wet climates when attainable interven-
tion coverage is 60 % or lower. However, when intervention coverage of 80 % is attainable, then malaria prevalence 
drops quickly in all geographic regions, even when factoring in the greater expense of the higher coverage against a 
constant budget.
Conclusions: The model provides a qualitative decision-making tool to weigh alternatives and guide malaria eradica-
tion e orts. A one-size- ts-all campaign is found not to be cost-e ective; it is better to consider geographic variations 
and changes in malaria transmission over time when determining intervention strategies.
Keywords: Malaria policy, Operations research, Compartment model, Integer programming
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Background
Malaria remains a lethal disease a ecting an estimated 
200 million people and killing 627,000 in 2012 [1].   ere 
are a variety of interventions for treating or preventing 
malaria infection, but the use of these interventions is 
hindered by scarcity of resources. Mathematical models 
provide a useful tool for evaluating intervention strat-
egies and studying the relative e ectiveness of inter-
ventions.   ese evaluations will become increasingly 
useful as success with malaria elimination is predicted to 
change transmission dynamics. In fact, the WHO Global 
Malaria Programme cites the speci c need for operations 
research models to determine the best intervention strat-
egies in areas where transmission dynamics are changing 
as malaria is being eliminated [2].
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In this paper, an integer linear program (ILP) and a 
coupled susceptible-infected-recovered (SIR) compart-
ment model are developed to create a decision-making 
tool for planning future interventions.   e model sug-
gests the best strategy for minimizing person-days of 
malaria infection over a 5-year period given an initial 
population, cost of each intervention, and a budget con-
straint.   e model allows for the possibility of a malaria 
vaccine in combination with other interventions. Simula-
tions are performed in which the budget, the e cacy of 
the interventions, and their cost are varied to determine 
the sensitivity of the optimal policy to these parameters.
Interventions
  ere are many existing methods to prevent or treat 
malaria infection.   e model will consider the following 
 ve interventions and their combinations.
Long-lasting insecticidal nets (LLINs) cover sleeping 
individuals during the night when mosquito biting can 
be highest. When intact, the nets block mosquitoes from 
reaching humans.   e insecticides work by deterring 
mosquitoes from feeding and by killing female mosqui-
toes that come in contact with the net. LLINs can remain 
e ective for multiple years [3]. In fact, the WHO Pesti-
cide Evaluation Scheme 2005 guidelines state that LLINs 
should survive at least 3 years of recommended washing 
and use [4].
Indoor residual spraying (IRS) is another insecticidal 
prevention method. IRS is believed to deter mosquitoes 
from entering sprayed areas and to kill female Anopheles 
mosquitoes that rest on sprayed surfaces after feeding. 
(Resting after feeding is a hallmark of some mosquito 
species while others prefer to rest outdoors [5]). His-
torically, IRS with an insecticide called dichlorodiphe-
nyltrichloroethane was e ective in reducing malaria in 
Europe, Asia, and Latin America. However, as insecticide 
use increases, insecticide resistance has been observed in 
some mosquito populations in Africa, and new insecti-
cides must be used [1].
Intermittent preventive therapy (IPT) is the regular 
administration of a drug like sulfadoxine–pyrimetham-
nine to decrease morbidity due to malaria in infants, chil-
dren, and pregnant women. IPT decreases the chance of 
developing symptoms after being bitten by an infected 
mosquito [6].   ere is evidence that children withstand 
acute infection better than adults. However, in endemic 
areas, adults develop acquired immunity from repeated 
exposures, and children remain more susceptible to high 
levels of parasitaemia (parasite density in the blood) [7]. 
Most of the 627,000 people killed by malaria in 2012 were 
children in Africa, so giving IPT to infants, children, and 
pregnant women treats the most vulnerable population 
while limiting the risk of spreading drug resistance [1].
Artemisinin combination therapy (ACT) can be used to 
treat a patient after they contract malaria.   is is the best 
treatment for uncomplicated P. falciparum malaria when 
con rmed by rapid diagnostic tests (RDT) [1, 8]. ACT 
kills the parasites that cause symptoms and may destroy 
or disable the gametocytes that are responsible for infect-
ing mosquitoes [9]. Both these factors mean that ACT 
increases the recovery rate.
Many malaria vaccines are in development, and one 
has gone through Phase III clinical trials.   e complex 
life-cycle of the malaria parasite makes it possible to 
intervene at many stages. Vaccines that target di erent 
forms of the parasite will operate by di erent mecha-
nisms, but in general, a vaccine would decrease the 
chance of developing symptoms and increase the recov-
ery rate if infected.   e leading malaria vaccine candidate 
is the RTS,S malaria vaccine. It is an antigen composed of 
the RTS and S proteins.   e RTS,S vaccine is a pre-eryth-
rocytic vaccine that presents circumsporozoite protein 
(CSP) from malaria sporozoites to the immune system. 
CSP is a parasitic surface protein that is an important 
part of the invasion of hepatocytes by sporozoites [10]. 
Such a vaccine will decrease the probability that a sus-
ceptible person becomes infected after a bite from an 
infectious mosquito. Moreover, it is believed the vaccine 
could increase a person’s recovery rate by increasing their 
exposure to asexual blood-stage parasites, thereby boost-
ing their immunity [10]. (By contrast, a transmission-
blocking vaccine that acts in mosquitoes would decrease 
the probability of transmission from an infectious mos-
quito but would not change the human recovery rate).
Literature review
  is paper extends a single-stage optimization model of 
Dimitrov et al.   eir model divides the country of Nige-
ria into approximately 270,000 cells and chooses one 
action (either a single intervention or no intervention) 
for each cell over a year, subject to budget constraints, to 
minimize societal costs caused by malaria infection.   e 
model also identi es optimal locations for supply dis-
tribution centres.   ey treat the societal bene t of each 
intervention as an exogenous parameter that depends 
on geographic characteristics.   is allows their model to 
consider geographic variability in malaria dynamics [11].
However, because malaria dynamics depend on the frac-
tion of the population that is infectious, a quantity that the 
interventions are themselves trying to reduce, the frame-
work of Dimitrov et al. does not permit the examination 
of multiyear e orts against malaria in which the optimal 
policy might vary over time as the malaria dynamics shift. 
  is paper extends the optimization model above to select 
interventions (or combinations thereof) over multiple 
years by explicitly incorporating malaria disease dynamics 
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over time in response to those interventions.   is is a 
novel approach that combines two areas of mathematics 
that do not regularly interact: ILP from the area of opera-
tions research and di erential equations modelling from 
the area of mathematical epidemiology.
  ere is a long history of mathematical models of 
malaria transmission, going back to the work of Sir 
Ronald Ross in the early 1900s [12, 13]. In recent years, 
malaria has drawn signi cant attention from the academic 
community. Epidemiologists have traditionally modelled 
the spread of malaria in a population using variations on 
the SIR model to capture di erent aspects of the disease. 
Mandal et al. survey the models found in the literature 
and o er a hierarchy based on model complexity [13].
In order for the model presented here to make informed 
choices about which interventions to distribute, the 
dynamics of how disease transmission change after 
treatment interventions must  rst be understood. Lind-
blade et al. and Killeen et al. study the protective e ect 
of insecticide-treated nets or LLINs [16]. Bousema et al. 
investigate how ACT reduces the circulation time of 
gametocytes, thereby reducing infectiousness [16]. Gar-
ner and Graves examine the community bene ts of ACT 
[17]. Chandramohan et al., Grobusch et al., and Aponte et 
al. quantify the protective e ects of IPT for infants [6, 18, 
19]. Pluess et al. review the e ects of IRS [5].   ese results 
are used to inform the model’s choice of disease transmis-
sion parameters, as described later under “E ects of inter-
ventions on SIR parameters” section.
  e model presented here includes in its portfolio of 
interventions a vaccine that is currently in development. 
Prosper et al. model the interaction between vaccine- and 
naturally-acquired immunity using a  ve-compartment 
model.   eir model augments the S, I, and R classes with 
a partially-immune (due either to vaccination or natural 
immunity) susceptible class and a moderately-infectious 
class for infected, partially-immune individuals.   ey 
 nd that disease burden can be decreased only if a highly 
e ective vaccine is coupled with a policy of actively treat-
ing asymptomatic infections in partially immune individ-
uals [20]. Bojang et al. report there is minimal potential 
e ect for a malaria vaccine given to adult men, and 
Asante et al. study the positive potential protective ben-
e ts of administering the vaccine to children [21, 22].
  ere are extensions to the SIR framework that are not 
considered here. Koella and Antia model the reduced 
e cacy of interventions due to the spread of drug-
resistant strains of malaria [23].   e model presented 
here does not incorporate drug-resistance, so any policy 
recommended by the model should be evaluated in this 
context. Other researchers, for example Dawes et al. [24] 
and Koudou et al. [25], focus on the mosquitoes’ plas-
modial transmission dynamics by analysing the e ects of 
interventions on mosquito morbidity and mortality rates 
and the usefulness of the resulting manipulation of said 
rates.   e changing mosquito population is not mod-
elled explicitly; instead the e ects of interventions on the 
mosquito population are represented as changes in the 
parameter values used in the human SIR model.
While the above references provide detailed models of 
malaria’s complex dynamics, this paper presents a sim-
ple SIR model that accommodates the e ects of several 
types of interventions, while maintaining the computa-
tional tractability required by the optimization model. In 
the next section, the model and simulation approach are 
described in greater detail.
Methods
  is paper considers the problem of allocating malaria 
treatments to many regions when limited by scarce 
resources.   ere is assumed to be a  xed annual budget 
shared across several geographic regions having di erent 
initial incidences and transmission rates of malaria and 
di erent unit costs for distributing treatment. A port-
folio of interventions can be selected, including some 
in combination, each having its own e ects on malaria 
transmission. Each intervention is selected at a particular 
coverage, which is the percentage of the population that 
receives the intervention and uses it correctly. Social and 
economic losses are assumed to be proportional to the 
time spent infectious, so person-days of malaria infection 
is the chosen measure of the malaria burden.   e model 
identi es the optimal sequence of interventions and cor-
responding coverage percentages for each region and 
each year that minimizes the total infected person-days 
over a  xed time horizon.
An integer linear programming optimization model 
(ILP) suggests the best set of interventions in each year to 
minimize person-days of malaria infection over all time 
steps.   e ILP takes as input the number of person-days 
of malaria infection that occur when a given intervention 
is used on a population with a given initial prevalence 
of malaria.   e person-days of malaria infection is esti-
mated by a SIR di erential equations model of malaria 
transmission dynamics.
Integer linear programming (ILP) model
  e ILP relies on several sets, parameters, and decision 
variables, which are de ned here.
Sets
Geographic regions Because the cost of distributing an 
intervention to a particular district depends on its infra-
structure and ease of access to treatment, and the malaria 
transmission dynamics depend on its climate, districts 
are grouped into geographic regions, denoted by index g. 
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  e optimization model determines the number of dis-
tricts in each geographic region to receive a particular 
sequence of interventions.
Population states A population state, p, is a triplet, 
(S, I, R), that indicates the percentage of a district’s popula-
tion susceptible to (S), infected by (I), or recovered from 
and temporarily immune to (R) malaria. Each district 
begins a year in a particular population state and ends in 
a new population state that depends on how the chosen 
intervention a ects the malaria disease dynamics. (  e 
model for determining the disease progression is described 
in the “Di erential equations (DE) model” section).
Actions   e set of actions is the set of possible choices 
of intervention (including certain combinations of inter-
ventions, or the possibility of applying no intervention). 
  e choice of intervention at a determined coverage level 
in a district is referred to as an action, denoted by index i.
Parameters
Ainigpq  is an indicator variable whose value is 1 if 
action i applied to a district of geographic 
region g, initially in population state p causes 
a transition to population state q, and 0 
otherwise.
Aoutigp   is an indicator variable whose value is 1 if 
action i applied to a district of geographic 
region g, initially in population state p causes a 
transition to a di erent population state, and 0 
otherwise.
Bt  is the annual budget for year t; the combined 
cost of actions across all districts in year t 
must not exceed this value.
Cig  is the cost of action i in any district in geo-
graphic region g.
Ipg  is the number of districts in geographic region 
g that are initially in population state p at the 
 rst time step.
Lipg  is the number of person-days of malaria infec-
tion incurred in a district in geographic region 
g, initially in population state p, under action i.
N  is a number larger than the total number of 
population states.
T  is the time horizon, in years, considered by the 
model.
Decision variables
Ppgt  is the number of districts in geographic region 
g that are initially in population state p at the 
start of year t.
aOUTipgt   is the number of districts in geographic region 
g that are initially in population state p at the 
start of year t and are assigned action i.
aINipqgt  is the number of districts in geographic region 
g that are initially in population state p at the 
start of year t, are assigned action i, and end in 
population state q.
Model
Using these sets, parameters and decision variables, the 
following ILP can now be de ned.
  e objective function in expression (1) minimizes the 
cumulative person-days that each district spends in 
the infected state over the time horizon, as a function 
of the model’s choice of actions. Constraint (2) requires 
the chosen set of interventions to be within budget in 
each year. Constraint (3) initializes the population vari-
able at the start of the time horizon. Constraints (4), (5), 
(6) and (7) are bookkeeping constraints that keep track 
of the number of districts in each geographic region 
and population state as a function of the actions cho-
sen. Constraints (8) and (9) assure that districts transi-
tion out of population state p to population state q only 
when an appropriate action has been taken.   e last 
(1)min
 
t,i,p,g
LipgaOUTipgt
(2)s.t.
 
i,g
Cig
 
p
aOUTipgt ≤ Bt ?t
(3)Pp,g,t= 1 = Ipg ?p,g
(4)
 
p
Ppgt =
 
p
Pp,g,t+ 1 ?g, t
(5)
 
i
aOUTipgt = Ppgt ?p,g,t
(6)Ppgt +
 
i ,q
aINipqgt −
 
i
aOUTipgt = Pp,g,t+ 1 ?p,g, t
(7)
 
p
aINipqgt = aOUTiqgt ?i,q,g,t
(8)aINipqgt ≤ N · Ainigpq ?i,p,q,g,t
(9)aOUTipgt ≤ N · Aoutigp ?i,p,g,t
Ppgt ,aINipqgt ,aOUTipgt ≥ 0, integer ?i ,p,q,g, t
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constraint requires all decision variables to be nonnega-
tive integers.
Di erential equations (DE) model
Several of the parameters used by the ILP model, spe-
ci cally Ainigpq, Aoutigp  and Lipg depend on the dynamics of 
malaria progression.   e SIR model is a standard system 
of nonlinear ordinary di erential equations for analys-
ing the transmission of malaria [13, 23]. In this paper, 
the standard model is modi ed to use a coupled six-class 
compartment model with separate SIR compartments 
for treated and untreated individuals.   is coupling of 
treated and untreated SIR classes permits modelling of 
population-wide bene ts caused by decreased infectious-
ness of a treated subpopulation. For an initial popula-
tion state and action, this system of equations is solved 
to determine the population state after 1 year.   is yields 
the indicator parameters Ainigpq and Aoutigp .   e solution to 
this system of di erential equations is also used to esti-
mate the burden of malaria, measured in infected per-
son-days, during that year. For each district in geographic 
region g, beginning the year in a particular population 
state p, having been assigned action i, the infected class 
curve that results under those conditions is numerically 
integrated, multiplied by the district’s population.   is 
estimates the number of people who are infected over 
the year times the number of days for which they remain 
infected.   is number is then input into the linear pro-
gramming model as the value of Lipg.   is is pre-solved 
for all possible population states and actions, and the 
results are stored as input data for the ILP.
  e parameters, state variables and system of di eren-
tial equations are now de ned.
Parameters
au (at)  is the number of bites per mosquito per 
untreated (respectively, treated) human per 
day.
bu (bt)  is the transmission e cacy from infected 
mosquito to susceptible, untreated (resp., 
treated) human.
c  is the transmission e cacy from infected 
human to susceptible mosquito.
δ  is the daily birth rate and death rate. Constant 
population is assumed.
γu (γt)  is the recovery rate for untreated (resp., 
treated) people. Its reciprocal is the average 
time that a person is infected with malaria.
hu (ht)  is the force of infection, that is, the rate at 
which untreated (resp., treated) susceptible 
humans become infected with malaria.
mu (mt)  is the number of mosquitoes per untreated 
(resp., treated) human.
µ  is the mosquito mortality rate.
ω  is the duration of immunity without 
reinfection.
q  is the treatment coverage, the percentage of 
the population that receives a treatment and 
uses it correctly. It is assumed that the same 
percentage of newborns are born into the sus-
ceptible, treated class.   e remaining fraction, 
1− q, are born into the susceptible, untreated 
class.
ρu (ρt)  is rate of immunity loss for recovered 
untreated (resp., treated) humans.
τ  is the incubation period of malaria in the 
mosquito.
State variables
Su (St)  is the proportion of the population that is sus-
ceptible and untreated (resp., treated).
Iu (It)  is the proportion of the population that is 
symptomatic, infectious, and untreated (resp., 
treated).
Ru (Rt)  is the proportion of the population that 
is recovered with acquired immunity and 
untreated (resp., treated).
Model
  e proportions of the population belonging to each of 
the six classes can be determined by solving the following 
system of di erential equations:
Although on the surface, the equations for the untreated 
population and the equations for the treated population 
(10)dSudt = δ(1− q) − (δ+ hu)Su + ρuRu
(11)dIudt = huSu − (δ+ γu)Iu
(12)dRudt = γuIu − (δ+ ρu)Ru
(13)dStdt = δq − (δ+ ht )St + ρt Rt
(14)dItdt = ht St − (δ+ γt )It
(15)dRtdt = γt It − (δ+ ρt )Rt.
Page 6 of 23Dudley et al. Malar J  (2016) 15:133 
do not appear to be coupled, the coupling occurs with 
the parameters hu and ht, which are the force of infec-
tion parameters.   ey have been derived by Smith and 
McKenzie [26] to be:
Observe that these rates are functions of the total pro-
portion of infectious people, Iu + It, which couples the 
system of di erential equations.   e more infectious 
people there are in either the untreated or treated group, 
the faster the rate at which susceptible people in either 
group can become infected.
  e rates of immunity loss, ρu and ρt, are functions of 
hu and ht, respectively and further couple the system.   e 
procedure for deriving the rate of immunity loss has been 
shown by Aron and May [27].   ese equations assume 
that being exposed to malaria while recovering resets the 
duration of immunity.
  is is a general model that does not consider the e ect 
an intervention can have on the transmission of the dis-
ease. In the speci c case of ACT, a medication that clears 
infection rapidly, the length of time a malaria patient is 
carrying infectious gametocytes in her blood is signi -
cantly reduced [16, 28]. Because of this, the model makes 
the assumption that ACT clears parasites before the 
body has time to develop acquired immunity; therefore, 
infected people treated with ACT are assumed to skip the 
recovered class and transition directly back to the sus-
ceptible class. To re ect this, the indicator variable ψact is 
introduced, which equals 1 when ACT is chosen (either 
alone or in combination with another intervention), and 
0 otherwise.   e state equations for the untreated class 
are unchanged, and the equations for the treated classes 
become:
(16)hu = mua
2
ubuce− µτ(Iu + It )
µ + auc(Iu + It )
(17)ht = mt a
2
t bt ce− µτ(Iu + It )
µ + at c(Iu + It )
.
(18)ρu = hu + δeω(hu+δ) − 1
(19)ρt = ht + δeω(ht+δ) − 1
(20)dStdt = δq − (δ+ ht )St + ρt Rt + ψactγt It
(21)dItdt = ht St − (δ+ γt )It
(22)dRtdt = (1− ψact )γt It − (δ+ ρt )Rt
Observe that when ACT is used, infectious individuals 
bypass the recovered class and transition directly to the 
susceptible class.
Because a new portfolio of interventions is selected 
each year, the e ects of treatment are assumed to last for 
1 year, exactly. Some of the treatments are known to last 
longer; for instance, the insecticide coating on mosquito 
nets is believed to be e ective for 3 years, and vaccines in 
development currently have an e cacy of 3 years. How-
ever, assuming a duration of only 1 year is conservative: 
under this assumption, the model will underestimate the 
e cacy of the interventions, and the results expected to 
be seen in the  eld should be better. Under this assump-
tion, at the end of each year, the six-state population 
(Su,Iu,Ru,St,It,Rt) can be collapsed into a more compact 
three-state representation: (Su + St,Iu + It,Ru + Rt).
Coverage
  e coverage, q, refers to the percentage of the popula-
tion that receives a treatment and uses it correctly. For 
example, if at the start of the year, the percentages of the 
population who are susceptible, infected and recovered 
are given by (S, I, R), respectively, then the initial values 
of Su,Iu,Ru,St,It, and Rt for the di erential equations 
model will be (1− q)S,(1− q)I ,(1− q)R,qS,qI , and qR , 
respectively.
However, some interventions, such as IPT and vac-
cine, are assumed to be distributed only to newborns 
and children under the age of four. In these cases, the 
coverage, q, applies only to births and to the fraction of 
the population under the age of four. If x is the fraction 
of the population under the age of four, and (S, I, R) is 
the initial distribution of susceptible, infected and recov-
ered individuals in the population, then the initial values 
of Su,Iu,Ru,St,It, and Rt for the di erential equations 
model will be (1− qx)S,(1− qx)I ,(1− qx)R,qxS,qxI , 
and qxR.
Data
  e model relies on parameters governing intervention 
costs, malaria transmission, and intervention e cacy. 
When available, parameter values are estimated based 
on malaria research literature. When using country-spe-
ci c information, data from Kenya or its neighbours are 
used as it is more readily available and permits consist-
ency across parameters.   is paper also presents sensitiv-
ity analysis to understand how the model’s results would 
change under a range of scenarios concerning distribu-
tion costs, climate and intervention e cacy. In this sec-
tion, the costs of the interventions are described  rst, 
followed by the baseline parameter values used in the 
SIR model.   en, the changes in these parameter values 
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under interventions and sensitivity analysis scenarios are 
described.
Base costs of interventions
  e model parameter Cig is the per person, per year 
cost of action i in any district in geographic region g. 
  e cost of an action depends on the purchase price as 
well as transportation and distribution costs, which are 
assumed to be regional. For the base cost, the simulations 
use data provided by White et al., who survey cost and 
cost-e ectiveness data for LLIN, IRS, IPT, and ACT from 
all available sources and adjust it to 2009 USD [29].   e 
simulations primarily use data from Kenya, except where 
noted that no Kenya-speci c data was available; in these 
cases, cost estimates from nearby Ethiopia, Tanzania and 
Zimbabwe are used.
Listed here are the base costs for each intervention; the 
subsequent section describes how to modify those costs 
to re ect transportation and distribution costs in di er-
ent geographic regions.   ese are summarized in Table 1.
LLIN   e average cost of a single insecticide-treated 
mosquito net is 7.21 USD [29], and the WHO Pesticide 
Evaluation Scheme 2005 guidelines estimate a 3 year 
life span with recommended use [4]. Because the model 
assumes all actions expire at the end of 1 year, an annual 
cost per net of 2.40 USD is used, which is one-third the 
base cost of the net. Moreover, bed-sharing is a common 
practice that further reduces the per-person cost of each 
distributed net.   e World Health Organization recom-
mends the assumption that an LLIN will protect 1.8 peo-
ple, on average [30], making the annual per-person cost 
1.33 USD.
IRS   e IRS cost estimate assumes two rounds of 
household spraying with lambda cyhalothrin per person 
per year, at an annual cost of 2.22 USD [29].
IPT White et al. summarize cost estimates for distrib-
uting IPT to newborns, children and pregnant women. 
  e mean cost of distributing six bi-monthly doses of 
sulfadoxine–pyrimethamine to infants in Tanzania is 
reported to be 0.78 USD, and three doses per year to 
children in Kenya is 1.25 USD [29]. As roughly 25 % of 
children under the age of 4 are infants, the simulations 
use an estimated weighted average annual cost for IPT of 
1.13 USD.
ACT White et al. report malaria diagnosis and treat-
ment costs for a variety of diagnostic methods and treat-
ment types in several countries. For consistency, the 
simulation uses costs associated speci cally with RDT 
used in conjunction with ACT treatment in the countries 
of Tanzania and Zambia.   ese range from 3.63 USD 
to 6.72 USD, with an average of 4.82 USD per person 
treated [29]. Unlike interventions such as LLINs, which 
are assumed to be distributed to the entire treated class, 
ACT is distributed only to members of the treated class 
who experience a malaria infection.   erefore, the SIR 
model must estimate the number of new malaria infec-
tions per year to determine the annual cost of ACT. 
According to Eq. (21), new infections occur with rate 
ht St = dItdt + (δ+ γt )It. Note that dItdt  can be approximated 
by It (d+ ǫ)− It (d)ǫ  for small ǫ. Discretizing the year over 
which the treatment is available into 365 days and letting 
ǫ= 1 day, the number of new infections appearing on day 
d should be roughly It (d) − (1− (δ+ γt ))It (d − 1) times 
the total population. Summing this value over all days 
d should give an approximation of the number of new 
infections incurred during the year, and hence, the num-
ber of people who received ACT.
Vaccine Cost data for the RTS,S vaccine is not yet avail-
able since the vaccine is not yet on the market. Seo et al. 
use an estimate of 7 USD per dose for the vaccine after 
looking at recent introductory vaccine prices ranging 
from 1 to 15 USD [31].   ey also propose using 0.37 USD 
administration cost per vaccination based on the price 
for other vaccines used in Malawi in the Expanded Pro-
gram on Immunization (EPI). Because the RTS,S vaccine 
is administered in three doses, they estimate the total 
cost of the vaccine at 22.11 USD per person per year [31]. 
Adjusting their 2012 costs to 2009 values for consistency 
yields a cost of 20.66 USD per treated person per year 
[32].
Baseline SIR model parameter values
  e baseline parameter values used in the SIR model are 
now described; the following section discusses how the 
interventions and modelling assumptions a ect those 
values.   is information is summarized in Table 2.
  • au is the number of bites per mosquito per untreated 
human per day, which is estimated to be 0.25 [33].
  • bu is the transmission probability from infected mos-
quito to susceptible, untreated human, which is esti-
mated to be 0.022 [33].
Table 1 Baseline cost for using interventions, per treated 
person for 1 year, in 2009 USD [29–31]
Intervention Cost
None 0
LLIN 1.33
ACT 4.82
IPT 1.13
IRS 2.22
Vaccine 20.66
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  • c is the transmission probability from infected human 
to susceptible mosquito, which is estimated to be 
0.36 [33].
  • δ is the daily birth rate and death rate. In Kenya in 
2014, the estimated annual birth rate was 0.02827 
births per person, and the estimated annual death 
rate was 0.007 deaths per person [34]. Because the 
model assumes a constant population, the average 
of these, or 0.017635 births (deaths) per person per 
year, is converted using compounding to a daily birth 
(death) rate of δ= 4.7895× 10− 5.
  • γu is the recovery rate for untreated people. Fil-
ipe et al. estimate the average infectious period for 
untreated people to be 180 days, making γu = 1180 
[35].
  • mu is the mosquito density (number of mosquitoes per 
untreated human), which is estimated to be 20 [13].
  • µ is the mosquito mortality rate, estimated to be 
0.095 days−1 [35, 36].
  • ω is the duration of immunity without reinfection. 
  e value ω = 274 days, is based on an estimate that 
immunity lasts between 6 and 12 months [37].
  • q is the treatment coverage, the percentage of the 
population that receives a treatment and uses it cor-
rectly.   ree levels of treatment coverage for each 
intervention are considered: high (60 %), medium 
(40 %), and low (20 %).
  • τ is the incubation period in the mosquito, estimated 
to be 10 days [36].
  • x is the fraction of the population that is age 4 years 
or younger, which was approximately 14.6 % in Kenya 
in 2014 [34].
  e expressions given in Eqs. (16), (17), (18) and (19) are 
used to determine the force of infection (hu and ht) and 
the recovery rate (ρu and ρt).
Note that the malaria transmission parameters, au, bu , 
c, and mu, are very location-speci c (see [36], p. 409). 
Table 2 Malaria transmission parameter values for the baseline, untreated case (corresponding to the subscript “u” ) 
and treatment cases (corresponding to the subscript “ t” )
In the baseline value column, an empty space means that the parameter does not apply to the baseline, untreated case. In the treatment value columns, an empty 
space means that the parameter is unchanged by that particular intervention
Symbol Description Baseline value
(untreated)
Treatment value
LLIN IRS IPT ACT Vaccine
au, at Bites per mosquito per human per day 0.25 [33] au(1− β) [15]
bu, bt Transmission e cacy from infected mosquito to 
susceptible, untreated human
0.022 [33] 0.0047 0.005
β Proportion of bites that would occur while sleeping 0.8 [15]
c Transmission e cacy from infected human to 
mosquito
0.36 [33]
δ Daily birth rate and death rate assuming constant 
population
4.7895∗ 10− 5 [34]
γu, γt Recovery rate in humans 1180 [35] 110 15.5
mu, mt Mosquitoes per human 20 [13] mu(1− βχLLIN) mu,IRS = mu(1− qχIRSu)
mt = mu(1− χIRSt ) [38]
µ Mosquito mortality rate 0.095 [35, 36]
ω Duration of immunity without reinfection 274 days [37]
q Treatment coverage 0.2, 0.4 or 0.6
τ Incubation period in mosquito 10 days [36]
x Fraction of the population 0.146 [34]
0–4 years of age
χLLIN Probability of mosquito mortality when exposed to 
a treated net
0.8 [14]
χIRSt Percent reduction in mosquito density in a house 
treated with IRS
0.95 [38]
χIRSu Percent reduction in mosquito density in an 
untreated house when all nearby houses are 
treated with IRS
0.5 [38]
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Adapting this model to any location would require re-
estimating these parameters.
E ects of interventions on SIR parameters
Each intervention, or combination of interventions, is 
modelled as a ecting a subset of the above parameters.
LLINs protect individual users by decreasing the biting 
rate, at, and by killing mosquitoes that contact the insec-
ticidal nets, thus decreasing mt.   e values of at and mt 
are estimated as follows:
  • Let β be the proportion of mosquito exposure that 
occurs during sleeping hours.
  • Let χLLIN  be the probability of mortality for a mos-
quito exposed to a treated net.
  • As before, let mu be the baseline mosquito density 
absent any treatment.
  en Killeen et al. [15] derive the value of at for people 
using LLIN as
and the value of mt for people using LLIN as
Although Fig. 5 in reference [15] shows a slight increase in 
overall protection for the treated class as a function of q, 
this increase is modest in the range of q considered here, 
and so mt is assumed to be independent of q. Additionally, 
Killeen et al. suggest that as treatment coverage increases 
in a population, even non-users of LLINs bene t from 
decreased mosquito density. However, the authors were 
unable to  nd empirical data to support a robust model 
of mosquito density in the untreated population as a func-
tion of treatment coverage; therefore, the model assumes 
that the untreated population experiences the baseline 
mosquito density, mu, for all values of q.
To determine the new biting rate, at, and the new 
mosquito density, mt, for the treated classes, Eqs. (23) 
and (24), respectively, are used with β = 0.8 [15] and 
χLLIN = 0.8 [14], and with au = 0.25, and mu = 20 as 
given earlier.
IRS decreases the number of mosquitoes per treated 
human, mt, in a similar manner as LLINs. Moreover, IRS 
can also decrease the mosquito density in untreated areas 
close to treated areas; thus, mu is also a ected by IRS 
[38]. Let χIRSt be the reduction in mosquito density in a 
house treated with IRS, and let χIRSu be the reduction in 
mosquito density in an untreated house when the treat-
ment coverage is 100 % in a nearby area.   en the value 
of mt for a house treated with IRS is
(23)at = au(1− β),
(24)mt = mu(1− βχLLIN ).
(25)mt = mu(1− χIRSt )
  e value of mu when IRS is used at coverage q is esti-
mated (based on the empirical results of Zhou et al. [38]) 
to be
As [38] report that the mosquito density in treated areas 
decreases by 95 %, and the mosquito density in untreated 
areas decreases by 50 % when the coverage in nearby 
treated areas is 100 %, the simulations use χIRSt = 0.95 
and χIRSu = 0.5, mu = 20 as given earlier, and q equal to 
the coverage associated with the selected action.
IPT decreases the probability, bt , that a susceptible 
person becomes infected after a bite from an infec-
tious mosquito. The authors were unable to find an 
estimate in the literature for the amount by which 
the transmission efficacy, bt , decreases when a per-
son is using IPT. However, data from several studies 
reported by Aponte et al. indicate that the protective 
efficacy against malaria in infants of 1 year of IPT is 
roughly 30 % [6]. As this should roughly correspond 
to the percentage decrease in new malaria infections 
observed in the SIR model output, the model was cali-
brated by solving the system of differential equations 
for a range of values for bt  and selecting the value of 
bt  that achieves a 30 % reduction in new malaria infec-
tions. The value bt = 0.0047 achieves this percentage 
reduction.
ACT dramatically reduces the length of time a malaria 
patient is carrying infectious gametocytes in her blood, 
possibly down to a mean infectious period of 10 days, so 
the simulations use γt = 110 days−1 [16, 17, 28].
Vaccine, like IPT, decreases the probability, bt, that a 
susceptible person becomes infected after a bite from 
an infectious mosquito. Additionally, a vaccine could 
increase the recovery rate, γt, by exposing the immune 
system to parasite proteins or decreasing the amount of 
parasites that reach the blood stage initially [10]. Olotu 
et al. report clinical trial results suggesting that the 
4-year reduction in malaria episodes among vaccinated 
children is 23.5–24.3 % [39]. As this should roughly 
correspond to the percentage decrease in new malaria 
infections observed in the SIR model output, the model 
was calibrated by solving the system of di erential equa-
tions for a range of values for both bt and γt and selecting 
the combination that achieves a roughly 24 % reduc-
tion in new malaria infections. Choosing bt = 0.005 and 
γt = 15.5 days−1 achieves this percentage reduction.
Possible actions that can be selected by the optimi-
zation model are to deploy no intervention, a single 
intervention, or a combination of two interventions. 
Although it is possible to consider combining any pair 
of interventions, for modelling simplicity, the only pairs 
(26)muIRS = mu(1− qχIRSu).
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of interventions considered are those whose coverage 
applies to the same segments of the population.   ere-
fore, because IPT and vaccines are assumed in the model 
to be distributed only to newborns and children under 
the age of four, while LLIN, ACT and IRS are applied to 
the general population, the combinations considered are 
IPT with vaccine, LLIN with ACT, LLIN with IRS, or 
ACT with IRS.
When two interventions are used in combination, it 
is assumed that the covered segment of the population 
receives both treatments, and the uncovered segment 
receives neither. If the two interventions a ect non-over-
lapping parameter sets, it is assumed the combination 
intervention will a ect the union of both sets of param-
eters in the same manner as the individual interventions. 
However, some pairs of interventions act upon the same 
parameter. For example, in the case of LLIN combined 
with IRS, the mosquito density, mt is a ected by both 
interventions. Because it would be too optimistic to 
assume that the e ects of LLIN and IRS are additive, the 
model makes a more conservative assumption: the small-
est values of at, mu and mt o ered by either LLIN or IRS 
are used. For the IPT with vaccine combination, bt, the 
transmission e cacy from infected mosquito to suscep-
tible, treated human, is reduced by both interventions via 
di erent mechanisms, and γt is increased by the vaccine. 
  erefore, the smaller of the two bt values under IPT and 
vaccine (that given by IPT, of bt = 0.0047) and the value 
of γt = 15.5 yielded by the vaccine are used.
Sensitivity analysis simulations
  e optimal sequence of 5-year interventions in a  cti-
tious nation were simulated and analysed.   is nation 
consists of 4500 districts, each having a population of 
10,000 (for a total population of 45 million, compara-
ble to that of Kenya in 2014 [34]). An annual budget of 
Bt = 33.75 million USD is used, which corresponds to 
0.75 USD per person, per year. (  is is comparable to 
the budget for the President’s Malaria Initiative (PMI) in 
Kenya, which in 2013 was 34,256,770 USD [40]).
Each of the 4500 districts is characterized as belonging 
to one of nine geographic regions, which in turn are char-
acterized by one of three distribution regions and one of 
three climate regions. 500 districts belong to each of the 
nine possible combinations. Distribution regions catego-
rize districts by how inexpensively (relative to the base-
line costs given earlier) interventions can be distributed 
to the district. Rural and remote areas are likely to experi-
ence higher-than-baseline distribution costs due to hav-
ing worse road infrastructure and lower access to health 
centres. Centrally located urban areas are likely to expe-
rience lower-than-baseline distribution costs. Districts 
categorized as having low distribution costs are assumed 
to have intervention costs that are 20 % lower than the 
baseline values given in Table 1. Districts categorized as 
having medium distribution costs will incur the baseline 
intervention costs, and districts categorized as having 
high distribution costs will incur intervention costs that 
are 20 % more than the baseline costs given in Table 1.
  e three climate regions, dry, moderate and wet, 
re ect the e ect climatic characteristics such as tempera-
ture and precipitation can have on mosquito population, 
and hence on malaria transmission dynamics.   e mod-
erate climate scenario assumes the baseline mosquito 
density given above of mu = 20 mosquitoes per human 
  e dry scenario assumes a mosquito density of mu = 5 
mosquitoes per human, and the wet scenario assumes a 
mosquito density of mu = 35 mosquitoes per human. 
Each region is also characterized by its own initial popu-
lation distribution amongst the S, I and R classes, which 
is chosen to be the steady-state population distribution 
observed when the SIR model is run for a long period of 
time from a variety of starting population distributions 
and assuming no intervention. For the moderate climate 
scenario, the steady-state distribution used for the ini-
tial distribution is 15 % susceptible, 15 % infected, and 
70 % recovered.   e dry scenario uses an initial steady-
state distribution of 60 % susceptible, 15 % infected, and 
25 % recovered.   e wet scenario uses an initial steady-
state population distribution of 10 % susceptible, 15 % 
infected, and 75 % recovered. (For computational trac-
tability, a population state resolution of  ve percentiles 
is used, and the SIR population state is rounded to the 
nearest 5 %, while requiring that the percentages over all 
compartments sum to one).
  ree e cacy scenarios are also considered to test the 
sensitivity of the model to the inherent uncertainty in the 
e cacy of the interventions.   e baseline e cacy sce-
nario uses the baseline parameter estimates described 
earlier and shown in Table 2.   e pessimistic e cacy sce-
nario assumes each parameter value for the treated class 
is 30 % “worse” than its baseline value, where “worse” 
means leading to greater malaria infections.   e optimis-
tic e cacy scenario assumes each parameter value for 
the treated class is 30 % “better” than its baseline value. 
In the case where making a treatment parameter 30 % 
worse than its baseline value ends up making it worse 
than the untreated baseline value, the value is capped at 
the untreated baseline; in this way, a situation is avoided 
in which the treated class might arti cially experience 
more malaria cases than the untreated class.
Results and discussion
  e results of running the model on this data are now 
presented. Because a simpli ed SIR model is used to 
estimate the social costs of malaria as a function of 
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interventions distributed, the purpose of this model is 
not to give exact estimates of reductions in person-days 
of malaria infection, but relative results that can be used 
by the optimization model to make choices between the 
various interventions.   e model provides qualitative 
insights about trends in the optimal interventions as cer-
tain parameters vary; these qualitative insights can then 
be used to o er high-level policy recommendations, as 
described below.
Table 3 and Fig. 1 provide the sequence of interventions 
allocated in each of the nine geographic regions (low, 
medium or high distribution costs, crossed with dry, 
moderate or wet climate) over a 5-year horizon in the 
baseline e cacy case.   e total person-days of malaria 
infection is found to be 4.506 billion. In Fig. 1, the  rst 
row of  gures corresponds to low distribution costs, the 
second row to medium distribution costs and the third 
row to high distribution costs. Likewise, each column of 
 gures corresponds to the same climate region (dry in 
red, moderate in yellow, wet in blue, from left to right). 
  e vertical axis on each graph lists in alphabetical order 
the interventions selected by the model at least once in at 
least one geographic region and the associated coverage. 
  e thickness of a path is proportional to the number of 
districts (out of 500) that were assigned that sequence 
of interventions. Table 3 gives the number of districts of 
each type that are assigned a particular sequence of inter-
ventions, as well as the resulting (S, I, R) population state 
after each year.
Note that for dry climate regions, the sequence of 
interventions is the same regardless of distribution cost, 
namely, ACT is distributed to 60 % of the population in 
year 1, and then no subsequent interventions are distrib-
uted in years 2–5.   e reason for this is that distributing 
ACT at a coverage of 60 % in year 1 eradicates (at least 
subject to rounding at a resolution of 5 %) malaria, driv-
ing the infected proportion of the population to zero. 
Per Eqs. (16) and (17), the force of infection is zero when 
the infected population is zero, and the disease cannot 
persist.
For the moderate climate regions, all districts are 
assigned ACT combined with LLIN at 60 % coverage 
in the  rst year, followed by ACT in combination with 
either LLIN or IRS at 60 % coverage in subsequent years.
  e sequence of interventions assigned in the wet 
regions at  rst glance appears more interesting. First, 
note that only low distribution cost districts, along with 
only two medium distribution cost and one high distri-
bution cost districts, receive any intervention during 
the  rst year. 126 high distribution cost districts never 
receive any intervention in any of the 5 years.   is is 
likely due to the budget constraint forcing the model to 
prioritize eliminating malaria in the dry climate regions 
during year 1 and leaving the harder-to-access wet 
regions largely untreated. In those wet districts receiv-
ing interventions, the chosen interventions are primarily 
LLIN with ACT at 60 % coverage, but as Table 3 shows, 
these interventions do little to reduce the prevalence of 
malaria in the population. An apparent steady-state con-
sists of 10 % of the population in the infected state even 
after several years of 60 % coverage of LLIN with ACT. 
  us, it can be inferred that combating malaria in the wet 
regions is not possible with the interventions considered 
at coverage percentages up to 60 %. As will be shown 
later, increasing the maximum coverage to 80 % is neces-
sary for reducing malaria in wet regions.
E ect of treatment e  cacy
  e sequence of interventions allocated in the nine 
geographic regions under the optimistic and pessimis-
tic e cacy scenarios, in which the disease transmission 
parameter values for the treated class are adjusted up or 
down by 30 %, can also be examined.   e optimistic case 
is depicted in Fig. 2, with the full set of results given in 
Table 4, and the results for the pessimistic case are given 
in Fig. 3 and Table 5.
In the optimistic case, note a reduction in person-days 
of malaria infection from 4.506 billion to 2.977 billion, or 
34 %. In year 1, the model focuses on eradicating (sub-
ject to rounding error) malaria in the dry and moderate 
climate regions by allocating LLIN, ACT or the two in 
combination. All but seven of the 1,500 wet climate dis-
tricts receive no intervention in year 1. In subsequent 
years, the wet climate districts receive 60 % coverage of 
LLIN with ACT, and ACT with IRS, with a handful of wet 
climate districts receiving IPT or no intervention dur-
ing years 1 and 2. Although it appears that the dry and 
moderate regions are also receiving interventions during 
years 2 through 5, this is an artifact of the optimization 
model: once the infectious population is driven to zero, 
there is no value in distributing further interventions; the 
model is allocating interventions in these regions simply 
to use up the available budget. Moreover, the prevalence 
of malaria in the wet regions appears to stabilize around 
10 % in year 5.   is is further indication that 60 % cover-
age is not su cient to diminish malaria prevalence in the 
wet regions, even if the interventions are assumed to be 
highly e ective.
In the pessimistic case, note an increase in person-days 
of malaria infection from 4.506 billion to 5.080 billion, or 
13 %. In year 1, resources are focused on rapidly reducing 
infections in the dry regions, by allocating 60 % coverage 
of ACT; remaining resources in year 1 are focused on the 
moderate climate regions. In subsequent years, the mod-
erate regions receive 60 % coverage of ACT combined 
with either IRS or LLIN; the remaining budget is used 
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Table 3 Optimal 5-year (Y1 through Y5) sequences of interventions for the baseline e  cacy scenario
Geographic region refers to the climate region and distribution cost pair, where the climate region is dry (D), moderate (M) or wet (W), and the distribution cost is low 
(L), medium (M) or high (H). Number of districts refers to the number of districts that were assigned a given trajectory. Initial population state is the starting (S, I, R) 
percentages of the region; the end population state for a given year is the resulting (S, I, R) state after distributing the corresponding intervention. The total person-
days of malaria infection in this scenario is 4.506 billion
Geographic
region
Number of
districts
Initial
population state
Y1 intervention
(end pop. state)
Y2 intervention
(end pop. state)
Y3 intervention
(end pop. state)
Y4 intervention
(end pop. state)
Y5 intervention
(end pop. state)
(D, L) 500 (60, 15, 25) ACT 60 % None None None None
(90, 0, 10) (95, 0, 5) (100, 0, 0) (100, 0, 0) (100, 0, 0)
(D, M) 500 (60, 15, 25) ACT 60 % None None None None
(90, 0, 10) (95, 0, 5) (100, 0, 0) (100, 0, 0) (100, 0, 0)
(D, H) 500 (60, 15, 25) ACT 60 % None None None None
(90, 0, 10) (95, 0, 5) (100, 0, 0) (100, 0, 0) (100, 0, 0)
(M, L) 500 (15, 15, 70) LLIN_ACT 60 % ACT_IRS 60 % ACT_IRS 60 % ACT_IRS 60 % ACT_IRS 60 %
(65, 5, 30) (80, 5, 15) (85, 5, 10) (85, 5, 10) (85, 5, 10)
(M, M) 500 (15, 15, 70) LLIN_ACT 60 % ACT_IRS 60 % ACT_IRS 60 % ACT_IRS 60 % LLIN_ACT 60 %
(65, 5, 30) (80, 5, 15) (85, 5, 10) (85, 5, 10) (75, 10, 15)
(M, H) 500 (15, 15, 70) LLIN_ACT 60 % ACT_IRS 60 % ACT_IRS 60 % ACT_IRS 60 % LLIN_ACT 60 %
(65, 5, 30) (80, 5, 15) (85, 5, 10) (85, 5, 10) (75, 10, 15)
(W, L) 395 (10, 15, 75) LLIN_ACT 20 % ACT_IRS 60 % LLIN_ACT 60 % LLIN_ACT 60 % LLIN_ACT 60 %
(25, 10, 65) (65, 5, 30) (60, 10, 30) (60, 10, 30) (60, 10, 30)
(W, L) 105 (10, 15, 75) LLIN_ACT 60 % LLIN_ACT 60 % LLIN_ACT 60 % LLIN_ACT 60 % LLIN_ACT 60 %
(60, 5, 35) (60, 10, 30) (60, 10, 30) (60, 10, 30) (60, 10, 30)
(W, M) 276 (10, 15, 75) None LLIN_ACT 60 % LLIN_ACT 60 % LLIN_ACT 60 % LLIN_ACT 60 %
(10, 15, 75) (60, 5, 35) (60, 10, 30) (60, 10, 30) (60, 10, 30)
(W, M) 136 (10, 15, 75) None LLIN_ACT 20 % ACT_IRS 60 % LLIN_ACT 60 % LLIN_ACT 60 %
(10, 15, 75) (25, 10, 65) (65, 5, 30) (60, 10, 30) (60, 10, 30)
(W, M) 59 (10, 15, 75) None None LLIN_ACT 60 % LLIN_ACT 60 % LLIN_ACT 60 %
(10, 15, 75) (10, 15, 75) (60, 5, 35) (60, 10, 30) (60, 10, 30)
(W, M) 22 (10, 15, 75) None None None LLIN 20 % LLIN_ACT 60 %
(10, 15, 75) (10, 15, 75) (10, 15, 75) (25, 10, 65) (55, 10, 35)
(W, M) 3 (10, 15, 75) None None IPT 40 % LLIN 20 % LLIN_ACT 60 %
(10, 15, 75) (10, 15, 75) (10, 15, 75) (25, 10, 65) (55, 10, 35)
(W, M) 2 (10, 15, 75) None IPT 40 % LLIN_ACT 60 % LLIN_ACT 60 % LLIN_ACT 60 %
(10, 15, 75) (10, 15, 75) (60, 5, 35) (60, 10, 30) (60, 10, 30)
(W, M) 1 (10, 15, 75) IPT 20 % LLIN_ACT 60 % LLIN_ACT 60 % LLIN_ACT 60 % LLIN_ACT 60 %
(10, 15, 75) (60, 5, 35) (60, 10, 30) (60, 10, 30) (60, 10, 30)
(W, M) 1 (10, 15, 75) IPT 40 % LLIN_ACT 60 % LLIN_ACT 60 % LLIN_ACT 60 % LLIN_ACT 60 %
(10, 15, 75) (60, 5, 35) (60, 10, 30) (60, 10, 30) (60, 10, 30)
(W, H) 371 (10, 15, 75) None None None None LLIN_ACT 60 %
(10, 15, 75) (10, 15, 75) (10, 15, 75) (10, 15, 75) (60, 5, 35)
(W, H) 126 (10, 15, 75) None None None None None
(10, 15, 75) (10, 15, 75) (10, 15, 75) (10, 15, 75) (10, 15, 75)
(W, H) 1 (10, 15, 75) None None None None IPT 40 %
(10, 15, 75) (10, 15, 75) (10, 15, 75) (10, 15, 75) (10, 15, 75)
(W, H) 1 (10, 15, 75) None None IPT 40 % None LLIN_ACT 60 %
(10, 15, 75) (10, 15, 75) (10, 15, 75) (10, 15, 75) (60, 5, 35)
(W, H) 1 (10, 15, 75) IPT 40 % IPT 40 % IPT 40 % IPT 20 % LLIN_ACT 60 %
(10, 15, 75) (10, 15, 75) (10, 15, 75) (10, 15, 75) (60, 5, 35)
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to allocate a variety of interventions in the wet regions. 
  e takeaway message here is that to minimize person-
days of malaria infection, the model chooses to focus 
resources on the dry and moderate climate regions; any 
remaining budget is allocated to the wet regions.
E ect of coverage
If a maximum coverage of 80 % (including both distri-
bution and compliance) is attainable, the results change 
dramatically. Table 6 gives the sequence of interventions 
assuming a baseline e cacy and possible coverage levels 
of 40 %, 60 and 80 % (rather than 20, 40 and 60 % used 
earlier), and using the same annual budget of 33.75 mil-
lion USD. In all geographic regions, the infected popu-
lation is driven to zero within 2 years, indicating that 
malaria is e ectively eradicated (at least subject to round-
ing at a resolution of 5 %).   us, achieving high cover-
age is crucial to rapid eradication of malaria, even with 
the annual budget held constant. Although intervention 
costs rise in proportion to the treatment coverage, the 
 xed budget is able to achieve markedly lower person-
days of malaria infection when 80 % coverage is achiev-
able as opposed to only 60 % (1.139 billion person days, 
as opposed to 4.506 billion person days,) although some 
of this e ect is likely due to rounding at resolution 5 %. 
  us, giving a smaller number of cities a higher coverage 
is more e ective than giving a larger number of cities a 
lower coverage. Moreover, it is only when 80 % coverage 
is attainable that the prevalence of malaria is reduced in 
the wet climate regions.
1 2 3 4 5
None
LLIN_ACT 60%
LLIN_ACT 20%
LLIN 20%
IPT 40%
IPT 20%
ACT_IRS 60%
ACT 60%
Low Distn. Cost, Dry Climate
Year
1 2 3 4 5
None
LLIN_ACT 60%
LLIN_ACT 20%
LLIN 20%
IPT 40%
IPT 20%
ACT_IRS 60%
ACT 60%
Low Distn. Cost, Moderate Climate
Year
1 2 3 4 5
None
LLIN_ACT 60%
LLIN_ACT 20%
LLIN 20%
IPT 40%
IPT 20%
ACT_IRS 60%
ACT 60%
Low Distn. Cost, Wet Climate
Year
1 2 3 4 5
None
LLIN_ACT 60%
LLIN_ACT 20%
LLIN 20%
IPT 40%
IPT 20%
ACT_IRS 60%
ACT 60%
Medium Distn. Cost, Dry Climate
Year
1 2 3 4 5
None
LLIN_ACT 60%
LLIN_ACT 20%
LLIN 20%
IPT 40%
IPT 20%
ACT_IRS 60%
ACT 60%
Medium Distn. Cost, Moderate Climate
Year
1 2 3 4 5
None
LLIN_ACT 60%
LLIN_ACT 20%
LLIN 20%
IPT 40%
IPT 20%
ACT_IRS 60%
ACT 60%
Medium Distn. Cost, Wet Climate
Year
1 2 3 4 5
None
LLIN_ACT 60%
LLIN_ACT 20%
LLIN 20%
IPT 40%
IPT 20%
ACT_IRS 60%
ACT 60%
High Distn. Cost, Dry Climate
Year
1 2 3 4 5
None
LLIN_ACT 60%
LLIN_ACT 20%
LLIN 20%
IPT 40%
IPT 20%
ACT_IRS 60%
ACT 60%
High Distn. Cost, Moderate Climate
Year
1 2 3 4 5
None
LLIN_ACT 60%
LLIN_ACT 20%
LLIN 20%
IPT 40%
IPT 20%
ACT_IRS 60%
ACT 60%
High Distn. Cost, Wet Climate
Year
Fig. 1 Sequence of interventions over a 5-year time horizon in the baseline e cacy scenario. The thickness of each line is proportional to the num-
ber of districts assigned a given sequence. Intervention sequences assigned to only a single district have been omitted from the  gure ( ve districts 
omitted in total). The total person-days of malaria infection in this scenario is 4.506 billion
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Because the 80 % coverage eradicates malaria so 
quickly in the model, the interpretation of the 5-year 
model results becomes less interesting. For this reason, 
the remainder of the results will be presented using the 
original coverage percentages of 20, 40 and 60 %, except 
where otherwise indicated.
E ect of budget
Previous work by Dimitrov et al. suggested that increas-
ing the budget would decrease malaria deaths roughly 
linearly up to a critical budget value, after which there 
would be diminishing marginal bene t to additional 
budget expenditures [11]. Using the baseline e cacy sce-
nario, the optimization problem was solved sequentially 
for budgets ranging from 15 million USD to 155 million 
USD in increments of 10 million USD, and person-days 
of malaria infection was plotted against budget. As seen 
in Fig. 4, the model’s results are consistent with Dimitrov 
et al. [11].   e person-days of malaria infection decrease 
linearly with an increase in budget until roughly 55 mil-
lion USD, after which diminishing marginal returns 
on budget increases are observed. Moreover, beyond a 
budget of 85 million USD, there can be no further reduc-
tion in person-days of malaria infection. Also shown in 
Fig. 4 is the plot of person-days of malaria infection in 
the baseline scenario when coverage up to 80 % is attain-
able.   e graph exhibits the same general shape, but with 
substantially lower values for the person-days of malaria 
infection. Moreover, even with a very large budget, 60 % 
coverage cannot achieve the low prevalence of malaria 
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None
LLIN_ACT 60%
LLIN 60%
IPT 40%
IPT 20%
ACT_IRS 60%
ACT 60%
ACT 40%
ACT 20%
Low Distn. Cost, Dry Climate
Year
1 2 3 4 5
None
LLIN_ACT 60%
LLIN 60%
IPT 40%
IPT 20%
ACT_IRS 60%
ACT 60%
ACT 40%
ACT 20%
Low Distn. Cost, Moderate Climate
Year
1 2 3 4 5
None
LLIN_ACT 60%
LLIN 60%
IPT 40%
IPT 20%
ACT_IRS 60%
ACT 60%
ACT 40%
ACT 20%
Low Distn. Cost, Wet Climate
Year
1 2 3 4 5
None
LLIN_ACT 60%
LLIN 60%
IPT 40%
IPT 20%
ACT_IRS 60%
ACT 60%
ACT 40%
ACT 20%
Medium Distn. Cost, Dry Climate
Year
1 2 3 4 5
None
LLIN_ACT 60%
LLIN 60%
IPT 40%
IPT 20%
ACT_IRS 60%
ACT 60%
ACT 40%
ACT 20%
Medium Distn. Cost, Moderate Climate
Year
1 2 3 4 5
None
LLIN_ACT 60%
LLIN 60%
IPT 40%
IPT 20%
ACT_IRS 60%
ACT 60%
ACT 40%
ACT 20%
Medium Distn. Cost, Wet Climate
Year
1 2 3 4 5
None
LLIN_ACT 60%
LLIN 60%
IPT 40%
IPT 20%
ACT_IRS 60%
ACT 60%
ACT 40%
ACT 20%
High Distn. Cost, Dry Climate
Year
1 2 3 4 5
None
LLIN_ACT 60%
LLIN 60%
IPT 40%
IPT 20%
ACT_IRS 60%
ACT 60%
ACT 40%
ACT 20%
High Distn. Cost, Moderate Climate
Year
1 2 3 4 5
None
LLIN_ACT 60%
LLIN 60%
IPT 40%
IPT 20%
ACT_IRS 60%
ACT 60%
ACT 40%
ACT 20%
High Distn. Cost, Wet Climate
Year
Fig. 2 Sequence of interventions over a 5-year time horizon in the optimistic e cacy scenario. The thickness of each line is proportional to the 
number of districts assigned a given sequence. Intervention sequences assigned to only a single district have been omitted from the  gure (four 
districts omitted in total). The total person-days of malaria infection in this scenario is 2.977 billion
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infection that 80 % coverage can achieve with even a 
small budget.
Additionally, the qualitative change in the interven-
tions chosen at di erent budget levels is evident in 
Fig. 5. When the budget is 15 million USD, for instance, 
most districts receive no intervention in most years. 
  ose that do receive 60 % coverage of ACT, either 
alone or in combination with either IRS or LLIN, or 
40 % coverage of IPT. (Although not shown in Fig. 5, 
the raw results from the simulation reveal that the dry 
regions receive interventions in year 1, which e ectively 
eradicates malaria in those regions; most of the moder-
ate climate regions receive interventions in most years, 
with a cluster of high distribution cost districts receiv-
ing no intervention in any of the 5 years; and the wet 
regions typically receive no intervention in most years). 
When the budget is 85 million USD, Fig. 5 shows that 
the number of districts receiving no intervention in 
some year drops sharply. (A closer look at the raw 
results reveals that all regions receive the maximum 
Table 4 Optimal 5-year (Y1 through Y5) sequences of interventions for the optimist ic e  cacy scenario
Geographic region refers to the climate region and distribution cost pair, where the climate region is dry (D), moderate (M) or wet (W), and the distribution cost is low 
(L), medium (M) or high (H). Number of districts refers to the number of districts that were assigned a given trajectory. Initial population state is the starting (S, I, R) 
percentages of the region; the end population state for a given year is the resulting (S, I, R) state after distributing the corresponding intervention. The total person-
days of malaria infection in this scenario is 2.977 billion
Geographic
region
Number of
districts
Initial
population state
Y1 intervention
(end pop. state)
Y2 intervention
(end pop. state)
Y3 intervention
(end pop. state)
Y4 intervention
(end pop. state)
Y5 intervention
(end pop. state)
(D, L) 500 (60, 15, 25) LLIN_ACT 60 % ACT 60 % ACT 20 % ACT 60 % None
(90, 0, 10) (95, 0, 5) (100, 0, 0) (100, 0, 0) (100, 0, 0)
(D, M) 500 (60, 15, 25) LLIN_ACT 60 % ACT 40 % ACT 40 % ACT 20 % None
(90, 0, 10) (95, 0, 5) (100, 0, 0) (100, 0, 0) (100, 0, 0)
(D, H) 500 (60, 15, 25) ACT 60 % ACT 60 % ACT 40 % ACT 60 % ACT 40 %
(85, 5, 10) (95, 0, 5) (100, 0, 0) (100, 0, 0) (100, 0, 0)
(M, L) 500 (15, 15, 70) LLIN_ACT 60 % ACT_IRS 60 % None ACT 40 % None
(65, 5, 30) (90, 0, 10) (95, 0, 5) (100, 0, 0) (100, 0, 0)
(M, M) 500 (15, 15, 70) LLIN_ACT 60 % ACT_IRS 60 % None ACT 20 % ACT 40 %
(65, 5, 30) (90, 0, 10) (95, 0, 5) (100, 0, 0) (100, 0, 0)
(M, H) 266 (15, 15, 70) LLIN_ACT 60 % ACT_IRS 60 % ACT 60 % None ACT 40 %
(65, 5, 30) (90, 0, 10) (95, 0, 5) (100, 0, 0) (100, 0, 0)
(M, H) 234 (15, 15, 70) LLIN 60 % ACT_IRS 60 % ACT 60 % None ACT 40 %
(60, 5, 35) (90, 0, 10) (95, 0, 5) (100, 0, 0) (100, 0, 0)
(W, L) 497 (10, 15, 75) None LLIN_ACT 60 % ACT_IRS 60 % ACT_IRS 60 % ACT_IRS 60 %
(10, 15, 75) (60, 5, 35) (80, 5, 15) (75, 10, 15) (75, 10, 15)
(W, L) 3 (10, 15, 75) IPT 40 % LLIN_ACT 60 % ACT_IRS 60 % ACT_IRS 60 % ACT_IRS 60 %
(10, 15, 75) (60, 5, 35) (80, 5, 15) (75, 10, 15) (75, 10, 15)
(W, M) 324 (10, 15, 75) None LLIN_ACT 60 % ACT_IRS 60 % ACT_IRS 60 % ACT_IRS 60 %
(10, 15, 75) (60, 5, 35) (80, 5, 15) (75, 10, 15) (75, 10, 15)
(W, M) 172 (10, 15, 75) None None LLIN_ACT 60 % ACT_IRS 60 % ACT_IRS 60 %
(10, 15, 75) (10, 15, 75) (60, 5, 35) (80, 5, 15) (75, 10, 15)
(W, M) 2 (10, 15, 75) IPT 40 % LLIN_ACT 60 % ACT_IRS 60 % ACT_IRS 60 % ACT_IRS 60 %
(10, 15, 75) (60, 5, 35) (80, 5, 15) (75, 10, 15) (75, 10, 15)
(W, M) 1 (10, 15, 75) None IPT 20 % LLIN_ACT 60 % ACT_IRS 60 % ACT_IRS 60 %
(10, 15, 75) (10, 15, 75) (60, 5, 35) (80, 5, 15) (75, 10, 15)
(W, M) 1 (10, 15, 75) None IPT 40 % LLIN_ACT 60 % ACT_IRS 60 % ACT_IRS 60 %
(10, 15, 75) (10, 15, 75) (60, 5, 35) (80, 5, 15) (75, 10, 15)
(W, H) 498 (10, 15, 75) None None LLIN_ACT 60 % ACT_IRS 60 % ACT_IRS 60 %
(10, 15, 75) (10, 15, 75) (60, 5, 35) (80, 5, 15) (75, 10, 15)
(W, H) 1 (10, 15, 75) IPT 40 % None LLIN_ACT 60 % ACT_IRS 60 % ACT_IRS 60 %
(10, 15, 75) (10, 15, 75) (60, 5, 35) (80, 5, 15) (75, 10, 15)
(W, H) 1 (10, 15, 75) IPT 40 % IPT 40 % LLIN_ACT 60 % ACT_IRS 60 % ACT_IRS 60 %
(10, 15, 75) (10, 15, 75) (60, 5, 35) (80, 5, 15) (75, 10, 15)
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of 60 % coverage of ACT in combination with IRS in 
all years, except for the dry regions, which receive no 
intervention in years 2 through 5 after malaria has been 
e ectively eradicated).
Figure 6 shows the percentage of the total popula-
tion that is in the infected class at the end of each of the 
5 years, when the annual budget is 15 million USD as 
compared to 85 million USD. A 15 million USD annual 
budget achieves a drop from 15 % infected to around 
8 % infected in steady state. An 85 million USD annual 
budget achieves an initial drop to around 3 % infected, 
which levels out to 5 % infected in steady-state. (Note 
that this contrasts with the results shown previously in 
Table 6 where if coverage of 80 % is attainable, malaria is 
eradicated with only a 33.75 million USD budget).
Role of vaccine
  e authors were surprised to observe that in all of the 
simulations across geographic regions, e cacy sce-
narios, maximum coverage, and budgets, the vaccine is 
almost never chosen, either alone or in combination with 
IPT. Although the annual cost per treated person is quite 
high (20.66 USD), the fact that it is distributed only to 
children under the age of four, comprising an estimated 
14.6 % of the population, makes its district-wide cost on 
par with that of the other interventions.   e model can 
be used to understand under what conditions a malaria 
vaccine would be a cost-e ective intervention by sys-
tematically lowering its cost and increasing its e cacy. 
Speci cally, the optimization model was solved on all 
combinations of bt = 0.001,0.005, or 0.009, γt = 12, 15.5, 
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LLIN_ACT 20%
LLIN 20%
IPT 60%
IPT 40%
IPT 20%
ACT_IRS 60%
ACT 60%
Low Distn. Cost, Dry Climate
Year
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LLIN 20%
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IPT 40%
IPT 20%
ACT_IRS 60%
ACT 60%
Low Distn. Cost, Moderate Climate
Year
1 2 3 4 5
None
LLIN_ACT 60%
LLIN_ACT 20%
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IPT 40%
IPT 20%
ACT_IRS 60%
ACT 60%
Low Distn. Cost, Wet Climate
Year
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None
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LLIN_ACT 20%
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IPT 20%
ACT_IRS 60%
ACT 60%
Medium Distn. Cost, Dry Climate
Year
1 2 3 4 5
None
LLIN_ACT 60%
LLIN_ACT 20%
LLIN 20%
IPT 60%
IPT 40%
IPT 20%
ACT_IRS 60%
ACT 60%
Medium Distn. Cost, Moderate Climate
Year
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None
LLIN_ACT 60%
LLIN_ACT 20%
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IPT 60%
IPT 40%
IPT 20%
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ACT 60%
Medium Distn. Cost, Wet Climate
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IPT 20%
ACT_IRS 60%
ACT 60%
High Distn. Cost, Dry Climate
Year
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None
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Fig. 3 Sequence of interventions over a 5-year time horizon in the pessimistic e cacy scenario. The thickness of each line is proportional to the 
number of districts assigned a given sequence. Intervention sequences assigned to only a single district have been omitted from the  gure ( ve 
districts omitted in total). The total person-days of malaria infection in this scenario is 5.080 billion
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or 130, and vaccinecost = 2,5,10, or 20.66 USD per 
person annually. Preliminary analysis of these results 
showed little in uence of either bt or γt on the number 
of times vaccine was selected; for most combinations of 
bt and γt, vaccine will be frequently chosen if the cost 
is 2 or 5 USD and will rarely be chosen if the cost is 10 
Table 5 Optimal 5-year (Y1 through Y5) sequences of interventions for the pessimist ic e  cacy scenario
Geographic region refers to the climate region and distribution cost pair, where the climate region is dry (D), moderate (M) or wet (W), and the distribution cost is low 
(L), medium (M) or high (H). Number of districts refers to the number of districts that were assigned a given trajectory. Initial population state is the starting (S, I, R) 
percentages of the region; the end population state for a given year is the resulting (S, I, R) state after distributing the corresponding intervention. The total person-
days of malaria infection in this scenario is 5.080 billion
Geographic
region
Number of
districts
Initial
population state
Y1 intervention
(end pop. state)
Y2 intervention
(end pop. state)
Y3 intervention
(end pop. state)
Y4 intervention
(end pop. state)
Y5 intervention
(end pop. state)
(D, L) 500 (60, 15, 25) ACT 60 % None None None None
(90, 0, 10) (95, 0, 5) (100, 0, 0) (100, 0, 0) (100, 0, 0)
(D, M) 500 (60, 15, 25) ACT 60 % None None None None
(90, 0, 10) (95, 0, 5) (100, 0, 0) (100, 0, 0) (100, 0, 0)
(D, H) 500 (60, 15, 25) ACT 60 % None None None None
(90, 0, 10) (95, 0, 5) (100, 0, 0) (100, 0, 0) (100, 0, 0)
(M, L) 494 (15, 15, 70) ACT 60 % ACT_IRS 60 % ACT_IRS 60 % LLIN_ACT 60 % LLIN_ACT 60 %
(60, 5, 35) (80, 5, 15) (75, 10, 15) (70, 10, 20) (70, 10, 20)
(M, L) 6 (15, 15, 70) ACT 60  % ACT_IRS 60 % LLIN_ACT 60 % LLIN_ACT 60 % LLIN_ACT 60 %
(60, 5, 35) (80, 5, 15) (75, 10, 15) (70, 10, 20) (70, 10, 20)
(M, M) 500 (15, 15, 70) LLIN_ACT 60  % LLIN_ACT 60 % LLIN_ACT 60 % LLIN_ACT 60 % LLIN_ACT 60 %
(65, 5, 30) (75, 10, 15) (70, 10, 20) (70, 10, 20) (70, 10, 20)
(M, H) 500 (15, 15, 70) LLIN_ACT 60  % LLIN_ACT 60 % LLIN_ACT 60 % LLIN_ACT 60 % LLIN_ACT 60 %
(65, 5, 30) (75, 10, 15) (70, 10, 20) (70, 10, 20) (70, 10, 20)
(W, L) 464 (10, 15, 75) None LLIN_ACT 60 % LLIN_ACT 60 % LLIN_ACT 60 % LLIN_ACT 60 %
(10, 15, 75) (60, 5, 35) (60, 10, 30) (60, 10, 30) (60, 10, 30)
(W, L) 35 (10, 15, 75) LLIN_ACT 60  % LLIN_ACT 60 % LLIN_ACT 60 % LLIN_ACT 60 % LLIN_ACT 60 %
(60, 5, 35) (60, 10, 30) (60, 10, 30) (60, 10, 30) (60, 10, 30)
(W, L) 1 (10, 15, 75) IPT 60  % LLIN_ACT 60 % LLIN_ACT 60 % LLIN_ACT 60 % LLIN_ACT 60 %
(10, 15, 75) (60, 5, 35) (60, 10, 30) (60, 10, 30) (60, 10, 30)
(W, M) 499 (10, 15, 75) None LLIN_ACT 60 % LLIN_ACT 60 % LLIN_ACT 60 % LLIN_ACT 60 %
(10, 15, 75) (60, 5, 35) (60, 10, 30) (60, 10, 30) (60, 10, 30)
(W, M) 1 (10, 15, 75) IPT 40  % LLIN_ACT 60 % LLIN_ACT 60 % LLIN_ACT 60 % LLIN_ACT 60 %
(10, 15, 75) (60, 5, 35) (60, 10, 30) (60, 10, 30) (60, 10, 30)
(W, H) 241 (10, 15, 75) None LLIN_ACT 60 % LLIN_ACT 60 % LLIN_ACT 60 % LLIN_ACT 60 %
(10, 15, 75) (60, 5, 35) (60, 10, 30) (60, 10, 30) (60, 10, 30)
(W, H) 140 (10, 15, 75) None None LLIN 20 % None None
(10, 15, 75) (10, 15, 75) (20, 10, 70) (5, 15, 80) (10, 15, 75)
(W, H) 109 (10, 15, 75) None LLIN 20 % None None None
(10, 15, 75) (20, 10, 70) (5, 15, 80) (10, 15, 75) (10, 15, 75)
(W, H) 3 (10, 15, 75) LLIN 20  % None IPT 40 % LLIN 20 % LLIN_ACT 60 %
(20, 10, 70) (5, 15, 80) (10, 15, 75) (20, 10, 70) (55, 10, 35)
(W, H) 2 (10, 15, 75) None IPT 60 % LLIN 20 % None None
(10, 15, 75) (10, 15, 75) (20, 10, 70) (5, 15, 80) (10, 15, 75)
(W, H) 2 (10, 15, 75) None LLIN 20 % None IPT 40 % IPT 60 %
(10, 15, 75) (20, 10, 70) (5, 15, 80) (10, 15, 75) (10, 15, 75)
(W, H) 1 (10, 15, 75) None None IPT 60 % LLIN 20 % IPT 20 %
(10, 15, 75) (10, 15, 75) (10, 15, 75) (20, 10, 70) (10, 15, 75)
(W, H) 1 (10, 15, 75) None IPT 60 % LLIN 20 % None LLIN_ACT 20 %
(10, 15, 75) (10, 15, 75) (20, 10, 70) (5, 15, 80) (25, 10, 65)
(W, H) 1 (10, 15, 75) None LLIN 20 % None IPT 40 % None
(10, 15, 75) (20, 10, 70) (5, 15, 80) (10, 15, 75) (10, 15, 75)
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Table 6 Optimal 5-year (Y1 through Y5) sequences of interventions for the baseline e  cacy scenario when the maximum 
coverage available for each intervention is 80 %
Geographic region refers to the climate region and distribution cost pair, where the climate region is dry (D), moderate (M) or wet (W), and the distribution cost is low 
(L), medium (M) or high (H). Number of districts refers to the number of districts that were assigned a given trajectory. Initial population state is the starting (S, I, R) 
percentages of the region; the end population state for a given year is the resulting (S, I, R) state after distributing the corresponding intervention. The total person-
days of malaria infection in this scenario is 1.139 billion, and in all geographic regions, malaria is eradicated over the 5-year time horizon
Geographic
region
Number of
districts
Initial
population state
Y1 intervention
(end pop. state)
Y2 intervention
(end pop. state)
Y3 intervention
(end pop. state)
Y4 intervention
(end pop. state)
Y5 intervention
(end pop. state)
(D, L) 500 (60, 15, 25) ACT 80 % ACT 60 % None ACT 40 % ACT 40 %
(90, 0, 10) (95, 0, 5) (100, 0, 0) (100, 0, 0) (100, 0, 0)
(D, M) 500 (60, 15, 25) ACT 80 % ACT 80 % ACT 80 % ACT 40 % ACT 60 %
(90, 0, 10) (95, 0, 5) (100, 0, 0) (100, 0, 0) (100, 0, 0)
(D, H) 500 (60, 15, 25) ACT 80 % None ACT 80 % ACT 40 % None
(90, 0, 10) (95, 0, 5) (100, 0, 0) (100, 0, 0) (100, 0, 0)
(M, L) 500 (15, 15, 70) ACT 80 % None ACT 80 % ACT 80 % None
(75, 0, 25) (95, 0, 5) (100, 0, 0) (100, 0, 0) (100, 0, 0)
(M, M) 500 (15, 15, 70) ACT 80 % ACT 40 % ACT 60 % ACT 80 % ACT 40 %
(75, 0, 25) (95, 0, 5) (100, 0, 0) (100, 0, 0) (100, 0, 0)
(M, H) 404 (15, 15, 70) IPT 40 % LLIN_ACT 80 % ACT 40 % ACT 80 % None
(20, 15, 65) (80, 0, 20) (95, 0, 5) (100, 0, 0) (100, 0, 0)
(M, H) 92 (15, 15, 70) ACT 80 % ACT 60 % ACT 40 % None None
(75, 0, 25) (95, 0, 5) (100, 0, 0) (100, 0, 0) (100, 0, 0)
(M, H) 3 (15, 15, 70) None LLIN_ACT 80 % ACT 40 % ACT 80 % None
(15, 20, 65) (80, 0, 20) (95, 0, 5) (100, 0, 0) (100, 0, 0)
(W, L) 500 (10, 15, 75) LLIN_ACT 80 % None ACT 40 % ACT 80 % ACT 80 %
(75, 0, 25) (95, 0, 5) (100, 0, 0) (100, 0, 0) (100, 0, 0)
(W, M) 500 (10, 15, 75) None ACT_IRS 80 % None ACT 60 % ACT 60 %
(10, 15, 75) (80, 0, 20) (95, 0, 5) (100, 0, 0) (100, 0, 0)
(W, H) 354 (10, 15, 75) None ACT_IRS 80 % ACT 40 % ACT 40 % None
(10, 15, 75) (80, 0, 20) (95, 0, 5) (100, 0, 0) (100, 0, 0)
(W, H) 146 (10, 15, 75) None LLIN_ACT 80 % None ACT 40 % None
(10, 15, 75) (75, 0, 25) (95, 0, 5) (100, 0, 0) (100, 0, 0)
0
1
2
3
4
5
6
7
15 25 35 45 55 65 75 85 95 105 115 125 135 145 155
Inf
ec
 o
ns
 
(b
illi
on
s o
f p
er
so
n-
da
ys
 ov
er
 5 
ye
ar
s)
Annual Budget (millions USD)
60% Coverage 80% Coverage
Fig. 4 Total person-days of malaria infection over 5-year horizon as a function of annual budget in the baseline e cacy scenario. The solid line cor-
responds to a maximum attainable coverages of 60 %. The dashed line corresponds to a maximum attainable coverage of 80 %
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or 20.66 USD.   erefore, it can be concluded that cost 
is a driving factor in the choice to select vaccines over 
other interventions. Figure 7 shows the number of dis-
tricts receiving vaccine, either alone or in combination 
with IPT, over the 5-year time horizon as a function of 
vaccine cost, for the baseline e cacy scenario and using 
bt = 0.005, and γt = 15.5. When the vaccine cost is 2 USD 
per person, it is selected quite often, but is selected far 
less frequently when the cost is 5 USD. Moreover, it is 
almost never selected at a cost of 10 or 20.66 USD. 
Shown in the same  gure is the person-days of malaria 
infection in those same instances. Reducing the vaccine 
cost from 20.66 USD per person to 2 USD per person 
yields only a 1.5 % reduction in person-days of malaria 
infection, from 4.51 billion to 4.44 billion.
Role of time horizon
An important motivation underlying this work is the idea 
that distributing an intervention changes the malaria 
transmission dynamics, which could a ect future inter-
vention choices. Figure 8 compares the interventions 
chosen in the  rst year of the 5-year time horizon to 
those chosen if the time horizon is only a single year. As 
mentioned above, in the  rst year of the 5-year time hori-
zon, resources are focused primarily on the dry and mod-
erate climate regions that receive either ACT alone at 
60 % coverage, or ACT in combination with LLIN at 60 % 
coverage. Most of the medium-to-high distribution cost 
districts in the wet regions receive no treatment during 
year 1. Nearly 400 of the low distribution cost districts in 
the wet regions get 20 % coverage of LLIN with ACT, and 
the remaining 100 get 60 % coverage of LLIN with ACT. 
By contrast, if only a 1-year time horizon is used, the 
solution changes. Dry regions (at all distribution costs) 
again receive ACT alone at 60 % coverage. Moderate cli-
mate regions having low or medium distribution costs 
receive LLIN in combination with ACT at 60 % coverage, 
as do 324 moderate climate regions having high distribu-
tion costs. However, now 175 moderate climate districts 
having high distribution costs drop down to no interven-
tion, and in return, all 500 wet climate districts having 
low distribution costs receive LLIN with ACT at 60 % 
coverage, which is substantially higher than before.   us, 
incorporating a multi-year planning horizon that antici-
pates changes in the malaria transmission as a result of 
the interventions distributed does indeed a ect the opti-
mal choice of intervention.
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Fig. 5 Interventions chosen (in district-years) under a 15 million USD annual budget as compared to an 85 million USD annual budget, aggregated 
over all geographic regions and a 5-year time horizon in the baseline e cacy scenario
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Role of climate
  ere is a noticeable qualitative di erence in the types 
of treatments distributed to the three climate regions 
considered. Aggregating over all years and distribution 
cost categories for the baseline e cacy scenario, the  rst 
row of Fig. 9 shows the number of districts receiving 
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baseline e cacy scenario
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Fig. 8 First-year interventions chosen in a 1-year time horizon versus a 5-year time horizon, by climate region, in the baseline e cacy scenario
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each type of treatment, separated by climate region. Dry 
regions are adequately served by ACT alone; moderate 
regions require ACT in combination with either LLIN 
or IRS; and wet regions get LLIN alone, LLIN with ACT, 
ACT with IRS, and a handful of others (though as dis-
cussed earlier, this variety is likely the result of the model 
using the available budget because no treatment at 60 % 
coverage is very successful at reducing malaria in the wet 
regions).
If a lower-cost vaccine is available at 2 USD per person 
per year, the second row of Fig. 9 shows that dry regions 
again receive exclusively no intervention and ACT, and 
moderate regions again receive exclusively ACT in com-
bination with either IRS or LLIN. Now, however, in the 
wet regions, the number of years of “no intervention” 
drops signi cantly, from 2725 to 70, and vaccine use, at 
either 40 or 60 % coverage, comprises nearly 50 % of the 
pie chart.
  e takeaway messages are that a single choice of inter-
vention across all climate types is unlikely to be optimal, 
and that the development of a low-cost malaria vaccine is 
likely to be of greatest use in regions with high mosquito 
densities; drier areas are better served by ACT, alone or 
in combination with IRS and LLIN.
Conclusions
Because the model is very sensitive to the disease transmis-
sion parameter values used, it is best suited for qualitative 
interpretations about relative bene ts of certain interven-
tions. For instance, while common sense might suggest that 
intervention resources should be focused on wet climate 
regions with high mosquito counts, the results of the simu-
lations with a maximum coverage of 60 % suggest the oppo-
site: to reduce person-days of malaria infection, it might 
be better to invest resources on areas where interventions 
can dramatically reduce the prevalence of malaria, rather 
than expend resources on areas where malaria is likely to 
persist, despite best e orts. But if coverage closer to 80 % 
is attainable, then malaria can be combatted in wet climate 
regions. Likewise, the model can illustrate the sensitivity of 
the optimal policy to certain parameters. For example, the 
optimal sequence of interventions varies by climate type (as 
represented by mosquito density), suggesting that a one-
size- ts-all approach to malaria eradication is not optimal. 
  e sensitivity of the model to parameter assumptions also 
signals that prior to using the model to guide policy in any 
given region, the choice of parameter values would  rst 
need to be calibrated to match known malaria prevalence 
rates in the region.
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Fig. 9 Interventions chosen by climate region when vaccine cost is 20.66 USD per treated person versus a low-cost vaccine having cost 2 USD per 
treated person, in the baseline e cacy scenario
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Future re nements of the model could address 
acquired resistance to interventions, age-dependent 
immunity, spatial e ects of human or mosquito migra-
tion, and computational tractability. Drug resistance 
in malaria parasites and insecticide resistance in mos-
quitoes are major challenges to control and eradication 
e orts [41–43]. Implementing resistance in this model 
would require tracking decreased e ectiveness of treat-
ment after use in multiple consecutive years.   is would 
increase the computational challenge of solving the 
model, however, as the costs and bene ts of choosing 
a particular intervention in a given year would depend 
not only on the (S, I, R) population state but also on the 
sequence of interventions chosen in prior years. Like-
wise, incorporating age-dependent immunity or spatial 
e ects would also require an increase in the number 
of population compartments in the (S, I, R) model. 
Already, computational power was limited, even using 
a 5 % population resolution.   e bottleneck appears to 
be in the formulation of the ILP using AMPL. Although 
the data  le is only 2 MB at 5 % resolution and 11 MB 
at 2 % resolution, loading the 5 % resolution data  le 
into AMPL took approximately 15 min on a 32-core, 
128 GB RAM parallel compute server located in the 
Harvey Mudd College Mathematics Department, and 
attempting to load the data  le for the 2 % resolution 
case exceeded the available 128 GB of RAM on the 
server. Once loaded, the 5 % resolution model was sub-
sequently solved by the CPLEX solver within seconds. 
  e technical sta  at the NEOS server (an online server 
for optimization solvers on which earlier tests were 
run [44–46]) who are familiar with these modelling 
languages suggested using a more e cient modelling 
language than AMPL for formulating the optimization 
model; this is left as future work.
Given the growing interest in malaria eradication, the 
WHO Global Malaria Programme cites the need for 
operations research studies to determine the best inter-
vention strategies in areas where transmission dynamics 
are changing as malaria is being eliminated.   ey also 
present a list of priority research questions that includes 
questions about safety, access, and community involve-
ment [2].   is paper presents a  exible modelling frame-
work that can guide such decisions.   e model permits a 
multi-year planning horizon over areas characterized by 
disparate infrastructure and climate. Given inputs of the 
per-person cost of each intervention and the e ects each 
intervention has on malaria disease transmission param-
eters, the model provides a sequence of interventions 
over a  xed time horizon that minimizes person-days of 
malaria infection subject to an annual budget. Moreo-
ver, this model can be adapted to the treatment of other 
infectious diseases.
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